Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Zoetis Inc. ZTS

Healthcare  —  Drug Manufacturers Specialty & Generic
71.05 0.78 1.11% as of 25 Sep
Market cap
$29.2B
P/E
11.7×
S&P 500 Member Dividend Champion (10y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Zoetis Inc. (ZTS) EV/Sales

As of 25 September 2026, Zoetis Inc. (ZTS) trades at a EV/Sales of 4.0×. Over the past ten years it has ranged from 4.0× (September 2026) to 15.9× (December 2021); the current reading is higher than 0% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.6× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 6.7× (20.70%)
FY2024 8.5× (23.78%)
FY2023 11.1× 23.00%
FY2022 9.1× (40.77%)
FY2021 15.3× 24.03%
FY2020 12.3× 13.84%
FY2019 10.8× 36.92%
FY2018 7.9× 6.81%
FY2017 7.4× 19.42%
FY2016 6.2× 6.83%

Quarterly

Period EV/Sales Change
Jun 2026 4.1× (33.58%)
Mar 2026 6.1× (9.06%)
Dec 2025 6.7× (11.15%)
Sep 2025 7.6× (4.71%)
42 more quarters

Against its own ten years

Low 4.0× High 15.9×
Ten-year median 8.8×
Current reading's percentile 0

EV/Sales against peers

Company EV/Sales
VTRS Viatris Inc. compare 2.3×
RDY Dr. Reddy's Laboratories Ltd compare 2.8×
ELAN Elanco Animal Health Incorporated compare 2.9×
HLN Haleon PLC Sponsored ADR compare 2.9×
TAK Takeda Pharmaceutical Co. compare 2.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 3.4×
ZTS Zoetis Inc. 4.0×
NBIX Neurocrine Biosciences, Inc. compare 4.1×
UTHR United Therapeutics Corporation compare 5.7×
Drug Manufacturers Specialty & Generic industry median 2.6×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ZTS